Lebanon, NH, United States of America

Xiaoli Meng

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Triterpenoid Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoli Meng. Retrieved from https://idiyas.com/inventor/xiaoli-meng-hwior9wf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Xiaoli Meng

Introduction

Xiaoli Meng is an accomplished inventor based in Lebanon, NH (US). She has made significant contributions to the field of enzyme inhibition. Her work focuses on developing methods and compositions that have the potential to advance therapeutic applications.

Latest Patents

Xiaoli Meng holds a patent titled "Methods and Compositions for Irreversible Enzyme Inhibition." This patent represents her innovative approach to enzyme inhibition, showcasing her expertise and dedication to scientific advancement. She has 1 patent to her name.

Career Highlights

Xiaoli Meng is currently employed at Triterpenoid Therapeutics, Inc. Her role at the company allows her to apply her knowledge and skills in a practical setting, contributing to the development of new therapeutic solutions.

Collaborations

Xiaoli collaborates with Michael B. Sporn, enhancing her research and innovation efforts. Their partnership exemplifies the importance of teamwork in scientific discovery.

Conclusion

Xiaoli Meng's contributions to enzyme inhibition through her patent and work at Triterpenoid Therapeutics, Inc. highlight her role as a significant innovator in her field. Her dedication to advancing therapeutic methods is commendable and impactful.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…